PBAC's latest decision on Lutropin alfa: Recommended with restriction (2015). Considered for Stimulation of follicular development in women with severe luteinising hormone deficiency undergoing assisted reproductive technology.
PBAC outcome
Recommended with restriction
Authority Required
ICER (AUD/QALY)
Redacted
commercial-in-confidence
Submissions
1
first 2015
Submissions
1
2015 → 2015
Eligible population
Women with severe LH deficiency, particularly poor responders to rFSH-only treatment, undergoing controlled ovarian stimulation in assisted reproductive technology (IVF/GIFT).
Economic evaluation results are redacted (marked with ''' in the document). Step 2 base-case modelled evaluation for clinical pregnancy showed the intervention 'Dominates', but actual ICER values are commercially sensitive and not published in the PSD.